Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-008977
Filing Date
2016-11-01
Accepted
2016-11-01 16:21:31
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20160930x10q.htm 10-Q 1523730
2 EX-10.1 rigl-20160930ex1019d4c5c.htm EX-10.1 96884
3 EX-10.2 rigl-20160930ex102410c24.htm EX-10.2 366139
4 EX-10.3 rigl-20160930ex103294a81.htm EX-10.3 361590
5 EX-31.1 rigl-20160930ex3111aa1b4.htm EX-31.1 17861
6 EX-31.2 rigl-20160930ex31211aad9.htm EX-31.2 17883
7 EX-32.1 rigl-20160930ex321c0e1eb.htm EX-32.1 9424
  Complete submission text file 0001558370-16-008977.txt   5455333

Data Files

Seq Description Document Type Size
8 EX-101.INS rigl-20160930.xml EX-101.INS 901032
9 EX-101.SCH rigl-20160930.xsd EX-101.SCH 33515
10 EX-101.CAL rigl-20160930_cal.xml EX-101.CAL 37463
11 EX-101.DEF rigl-20160930_def.xml EX-101.DEF 103809
12 EX-101.LAB rigl-20160930_lab.xml EX-101.LAB 289205
13 EX-101.PRE rigl-20160930_pre.xml EX-101.PRE 201318
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 161965023
SIC: 2834 Pharmaceutical Preparations